Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jamie Dananberg currently holds 225,000 shares of Unity Biotechnology, Inc. (UBX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jamie Dananberg has been a net seller of UBX stock. They have purchased $0 and sold $21.9K worth of shares.
Jamie Dananberg's most recent insider trade was on Feb 19, 2026, when they sold 225,000 shares at $0.00 per share.
Jamie Dananberg serves as Executive at Unity Biotechnology, Inc. (UBX). They have executed 26 insider transactions totaling $21.9K over their tenure at the company.
Jamie Dananberg holds the position of Executive at Unity Biotechnology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Jamie Dananberg has shown a selling trading pattern, with $0 in total purchases and $21.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jamie Dananberg was on Mar 30, 2021, when they sold $119.7K worth of UBX shares. This transaction involved 40,564 shares at $2.95 per share.
Jamie Dananberg currently owns 225,000 shares of Unity Biotechnology, Inc. (UBX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jamie Dananberg's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jamie Dananberg has 26 Form 4 filings on record as an insider at Unity Biotechnology, Inc..
Set alerts for Jamie Dananberg and 40,000+ other insiders.